New research collaboration between Uppsala Monitoring Centre and CauseHealth

IMG_3676
UMC Director Marie Lindquist with Rani Anjum and Elena Rocca. Photo: UMC

At 1 October 2018, a new collaborative research project started at NMBU that brings CauseHealth into its second phase; of CauseHealth pharmacovigilance. Continue reading “New research collaboration between Uppsala Monitoring Centre and CauseHealth”

Living with complexity and big data. Causal dispositionalim enters pharmacovigilance

Ralph Edwards on dispositionalism in pharmacovigilance

We have seen a lot of interest in the CauseHealth approach and issues during these last years, especially among clinicians who see a need for a more person centered healthcare. Can this be useful also outside the clinic? Yes, according to senior medical advisor at the WHO Uppsala Monitoring Center for Drug Safety, Ralph Edwards. In a recent perspectives article in the UMC report, he argues that dispositionalism can be useful for dealing with complexity, individual variation and the patient’s unique context. Continue reading “Living with complexity and big data. Causal dispositionalim enters pharmacovigilance”